478 related articles for article (PubMed ID: 30014058)
1. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
[TBL] [Abstract][Full Text] [Related]
2. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
[TBL] [Abstract][Full Text] [Related]
3. Block copolymer@ZIF-8 nanocomposites as a pH-responsive multi-steps release system for controlled drug delivery.
Lei Z; Tang Q; Ju Y; Lin Y; Bai X; Luo H; Tong Z
J Biomater Sci Polym Ed; 2020 Apr; 31(6):695-711. PubMed ID: 31914358
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
[TBL] [Abstract][Full Text] [Related]
5. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells.
Dashti N; Akbari V; Varshosaz J; Soleimanbeigi M; Rostami M
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131971. PubMed ID: 38705336
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 'dual-key-and-lock' drug carriers for imaging and improved drug release.
Gao H; Zhang Y; Chi B; Lin C; Tian F; Xu M; Wang Y; Xu Z; Li L; Wang J
Nanotechnology; 2020 Oct; 31(44):445102. PubMed ID: 32668418
[TBL] [Abstract][Full Text] [Related]
8. A protein-sulfosalicylic acid/boswellic acids @metal-organic framework nanocomposite as anticancer drug delivery system.
Özsoy M; Atiroğlu V; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
Colloids Surf B Biointerfaces; 2021 Aug; 204():111788. PubMed ID: 33932885
[TBL] [Abstract][Full Text] [Related]
9. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system.
Javanbakht S; Pooresmaeil M; Namazi H
Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: A biocompatible pH-Responsive nanocarrier for gemcitabine release on MCF‑7 human breast cancer cells.
Abd Al-Jabbar S; Atiroğlu V; Hameed RM; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
Bioorg Chem; 2022 Jan; 118():105467. PubMed ID: 34781115
[TBL] [Abstract][Full Text] [Related]
11. High Biocompatible ZIF-8 Coated by ZrO
Su L; Wu Q; Tan L; Huang Z; Fu C; Ren X; Xia N; Chen Z; Ma X; Lan X; Zhang Q; Meng X
ACS Appl Mater Interfaces; 2019 Mar; 11(11):10520-10531. PubMed ID: 30801175
[TBL] [Abstract][Full Text] [Related]
12. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
[TBL] [Abstract][Full Text] [Related]
13. Core-shell noble-metal@zeolitic-imidazolate-framework nanocarriers with high cancer treatment efficiency in vitro.
He L; Pang K; Liu W; Tian Y; Chang L; Liu X; Zhao M; Liu Y; Li Y; Jiang X; Song R; Liu Y
J Mater Chem B; 2019 Feb; 7(7):1050-1055. PubMed ID: 32254772
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded Fe
Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
[TBL] [Abstract][Full Text] [Related]
15. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
16. Chromium-Doped Zinc Gallogermanate@Zeolitic Imidazolate Framework-8: A Multifunctional Nanoplatform for Rechargeable In Vivo Persistent Luminescence Imaging and pH-Responsive Drug Release.
Lv Y; Ding D; Zhuang Y; Feng Y; Shi J; Zhang H; Zhou TL; Chen H; Xie RJ
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1907-1916. PubMed ID: 30566326
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic Nucleation of Metal-Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core-Shell-Structured pH-Responsive Anticancer Drug Carriers.
Chen Y; Wu H; Yang T; Zhou G; Chen Y; Wang J; Mao C; Yang M
ACS Appl Mater Interfaces; 2021 Oct; 13(40):47371-47381. PubMed ID: 34582680
[TBL] [Abstract][Full Text] [Related]
18. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.
Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F
J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089
[TBL] [Abstract][Full Text] [Related]
19. Rational Design of Metal Organic Framework Nanocarrier-Based Codelivery System of Doxorubicin Hydrochloride/Verapamil Hydrochloride for Overcoming Multidrug Resistance with Efficient Targeted Cancer Therapy.
Zhang H; Jiang W; Liu R; Zhang J; Zhang D; Li Z; Luan Y
ACS Appl Mater Interfaces; 2017 Jun; 9(23):19687-19697. PubMed ID: 28530401
[TBL] [Abstract][Full Text] [Related]
20. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging.
Croissant JG; Zhang D; Alsaiari S; Lu J; Deng L; Tamanoi F; AlMalik AM; Zink JI; Khashab NM
J Control Release; 2016 May; 229():183-191. PubMed ID: 27016140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
